ARCHIVES

New Policy on Minor Changes in Trials Requires Halt in Patient Enrollment.

This article is from The Cancer Letter archive.

Vol. 34 No. 16 | April 25, 2008

Download PDF Visit The Full Archive

Related Articles

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

January 13, 2006

ANG1005 Demonstrates Activity In Patients with Brain Metastases

November 29, 2013

Academic Oncologists Losing Control Over Phase I Trials As For-Profits Expand

March 26, 2010

GM Corp, to Reimburse Marrow Transplants for Breast Cancer

March 15, 1996

Patient Satisfaction Was Crucial In ODAC Review Of Panretin

November 27, 1998

Weight An Indicator For Risk Of Developing Myeloma

August 31, 2007